Nutanix call volume above normal and directionally bullish 15:25 NTNX Bullish option flow detected in Nutanix with 23,551 calls trading, 14x expected, and implied vol increasing over 3 points to 55.26%. Dec-22 32.5 calls and Dec-22 30 calls are the most active options, with total volume in those strikes near 18,400 contracts. The Put/Call Ratio is 0.04. Earnings are expected on November 22nd. Show Related Items >> Monday Nutanix price target raised to $31 from $25 at Needham 09:08 NTNX, AVGO, VMW Needham analyst Mike Cikos raised the firm's price target on Nutanix (NTNX) to $31 from $25 and keeps a Buy rating on the shares. Following last week's speculation by The Wall Street Journal regarding takeover interest in the company, the analyst believes that a deal is "likely". Cikos adds that private equity is the leading possibility in the buyout scenario, also stating that the magnitude of the stock price gain on the news was "surprising" as Nutanix has become more 'takeover friendly' in recent months. The analyst further states that Broadcom's (AVGO pending acquisition of VMware (VMW) has created scarcity value for Nutanix.
Van the regional banks have turned over today. But Chase is still way up and BAC>? Not sure what's going on. JPMorgan Chase & Co. (JPM)-- GET in Under $110 NYSE - NYSE Delayed Price. 107.73+3.23(+3.09%) At close: 04:00PM EDT 109.83+2.10(+1.95%)<----------------- Pre-Market:08:10AM EDT #7519 Oct 4, 2022 Report
Badger Meter (BMI) Q3 Earnings & Revenues Top Estimates, Up Y/Y Should It be an IRA stock? Thu, October 20, 2022, 1:28 PM In this article: BMI -2.82% Badger Meter, Inc BMI reported earnings of 61 cents per share for third-quarter 2022, beating the Zacks Consensus Estimate of 60 cents. Also, the bottom line compared favorably with the year-ago quarter’s earnings of 54 cents. Net earnings in the reported quarter were $17.9 million compared with $15.9 million in the year-ago quarter. The year-over-year improvement can be primarily attributed to higher revenues. Quarterly net sales increased to $148 million from $128.7 million in the year-ago quarter. The 15% (up 17% excluding the unfavorable impact of the stronger US dollar) rise was primarily driven by robust customer demand. Also, the top line beat the consensus mark of $141.1 million. Following the announcement, shares of the company jumped 3.5% on Oct 19, 2022 and closed the session at $100.36. In the past year, shares have lost 3.5% compared with the Zacks sub-industry’s decline of 23.6% Zacks Investment Research Segmental Performance In the quarter under review, utility water sales rose 17%, owing to strong demand momentum. Strength in E-Series, ultrasonic meters, ORION Cellular endpoint sales, and higher BEACON Software-as-a-Service revenues acted as major tailwinds. Flow instrumentation sales increased 5% year over year, driven by continued strong order trends across the majority of end-market applications globally. However, it was partly offset by supply chain woes, which impacted manufacturing output. Other Details During the September-end quarter, gross profit was $57.5 million, up 12.4% year over year. The gross margin was 38.9%, down from the 39.8% recorded in the prior-year quarter. This downside in the margin was primarily due to rising electronic and other components, logistics and other costs. Operating earnings were $23.9 million or 16.1% of sales compared with $19.4 million and 15.1% in the year-earlier quarter. / / / / / / / / / / / / / My experience is when a company executes like this you can buy it even in a bad Bear market.
PE pf 44 of course is problematic but what about RS! For the year this stk is down less than 5%! Badger Meter, Inc. (BMI) NYSE - Nasdaq Real Time Price. 97.81-2.55 (-2.54%) At close: 03:59PM EDT 97.68 -0.13 (-0.13%) After hours: 04:01PM EDT
Badger Meter currently has a Zacks Rank #4 (Sell)<--- I don't get Zacks makes no sense.- 30+% growth that's hard to find....... I think Van was right about this one.---
IBD 50 Stocks To Watch: Darling Eyes Buy Point In Today's Market Rally Licensing SCOTT LEHTONEN 01:50 PM ET 10/18/2022 Today's IBD 50 Stocks To Watch pick — Darling Ingredients (DAR) — is one of the top stocks to watch as it eyes a fresh buy point. Even so, DAR stock dropped nearly 4% midday Tuesday after the company announced a key acquisition. Stocks To Watch: Darling Ingredients The Texas-based company operates locations in North and South America, Europe, Asia and Australia. It develops and produces natural ingredients from edible and nonedible bio-nutrients. On Tuesday, Darling announced it's buying Brazil's Gelnex, a collagen producer, for about $1.2 billion. Medical, pharmaceutical, sports medicine and research companies use its biomedical gelatin products. The company also serves the biofuel, agriculture and food industries. The food leader's adjusted Q2 earnings climbed just 5% to $1.23 per share, while sales jumped 38% to $1.65 billion vs. the year-ago period. Q3 earnings are expected to grow to $1.43 per share on $1.63 billion in revenue. There is no confirmed earnings report date yet. IBD Stock Ratings DAR stock shows a solid 92 out of 99 Earnings Per Share Rating and a perfect "A" SMR grade, according to IBD Stock Checkup. The SMR Rating analyzes a company's sales, margins and return on equity, scaling results from "A" (the best) to "E" (the worst). In 2021, pretax margins and return on equity measured 17% and 21%, respectively. Meanwhile, sales growth averaged 34% over the last four quarters. This stock to watch boasts a perfect 99 IBD Composite Rating, tops within the Agricultural Operations industry group. The subsector ranks 40th out of 197 IBD groups, up from 121st place three weeks ago. Stock Market Strategy And How To Invest And Take Gummies! -GBA Darling stock is building a cup-with-handle base with an 80.15 buy point, according to IBD MarketSmith pattern recognition. The relative strength line hit a new high last week, confirming the stock is a market leader. A strong RS line in a weak market environment is a key technical indicator of strength. Shares declined more than 3.5% Tuesday midday after the company agreed to acquire Brazilian collagen producer Gelnex for $1.2 billion in cash. Wait for a decisive breakout above the entry before deciding whether to purchase shares. The market trend should also be in a confirmed uptrend, rather than the current market in correction. Still, the stock's unusual strength is impressive during the ongoing market weakness, so this food leader is one of the top stocks to watch.
That's one of the reasons I like it, it's still pricey. There has to be a reason for that. That, and all things water.